相关实验视频

Updated: Jun 18, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

肺癌采用细胞疗法:鼓舞人心的TIL ACT进入中心阶段

Michael T Lotze¹, Markus Maeurer², Sergio A Quezada³

¹University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, Pennsylvania.

Cancer discovery

|August 2, 2024

概括

使用瘤透淋巴细胞 (TIL) 的细胞疗法Lifileucel在高级非小细胞肺癌中显示了21.4%的客观反应率. 这为超越黑色素瘤的新疗法提供了希望.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
细胞疗法细胞疗法

背景情况:

从自身瘤透性淋巴细胞 (TIL) 衍生出的细胞疗法Lifileucel,此前已经证明在晚期黑色素瘤中有效,导致FDA批准.
非小细胞肺癌 (NSCLC) 仍然是一个重大挑战,晚期的治疗选择有限.

研究的目的:

评估lifileucel在患有晚期非小细胞肺癌的患者中的疗效.
在这个患者群体中评估lifileucel的客观反应率 (ORR).

主要方法:

一项临床研究涉及使用lifileucel治疗的晚期非小细胞肺癌患者.
评估客观响应率作为主要终点.

主要成果:

肖恩菲尔德及其同事报告说,在接受lifileucel治疗的晚期非小细胞肺癌患者中,客观反应率为6/28 (21.4%).
这代表了新的瘤组织学中对细胞治疗的可测量反应.

结论:

这些发现表明,lifileucel在治疗高级非小细胞肺癌方面具有前景.
这项研究支持正在进行的努力,以优化瘤透淋巴细胞 (TIL) 治疗各种癌症类型.

更多相关视频

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...